Current perspectives on intravenous administration of digoxin

Area of Science:

• Pharmacology
• Cardiology
• Clinical Pharmacy

Background:

• Cardiac glycosides, including digoxin, have a long history of therapeutic use.
• Digoxin is a commonly prescribed cardiac glycoside due to its favorable pharmacokinetic profile.
• Intravenous (IV) digoxin administration offers distinct clinical advantages.

Purpose of the Study:

• To review the utility and administration of intravenous digoxin.
• To highlight the pharmacokinetic properties of IV digoxin.
• To emphasize the importance of patient monitoring for IV digoxin therapy.

Main Methods:

• Review of existing literature on cardiac glycosides and digoxin.
• Analysis of clinical indications for intravenous digoxin.
• Discussion of digoxin pharmacokinetics, including myocardial uptake and serum half-life.
• Guidelines for IV digoxin dosage and administration schedules.

Main Results:

• Intravenous digoxin provides rapid and extensive myocardial uptake.
• The serum half-life of IV digoxin is approximately 34 hours, similar to oral administration.
• Recommended dosing for IV digoxin involves divided doses every 4-8 hours, not exceeding 1.0 mg in 24 hours for a 70 kg patient.
• Potential for rapid digitalization, use when oral route is not feasible, and as adjunctive therapy.

Conclusions:

• Intravenous digoxin is a valuable therapeutic option for rapid cardiac digitalization and in specific clinical scenarios.
• Understanding digoxin pharmacokinetics and adhering to recommended dosages are crucial for optimizing patient outcomes.
• Effective patient monitoring, incorporating risk factor awareness and advanced technology, is vital for safe IV digoxin use.